Helicase Venture
1 Beacon Street, Floor 15, Boston, Massachusetts, 02108, United States
Overview
Helicase Venture is an investment firm focused on healthcare. Through our industry experience and domain expertise, we work closely with our portfolio companies and entrepreneurs to navigate the challenges and to grow together with the right opportunities.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Investment portfolio
- Ribbon Biolabs
Participated · Series A · Jan 2022
Ribbon Biolabs develops a proprietary automated enzymatic DNA synthesis platform guided by combinatorial optimization algorithms to assemble long, sub-genomic DNA molecules. The company validated its capabilities by producing a 10,000 bp molecule in May 2021 and a 20,000 bp molecule in December 2021. Founded in 2018 and operating from Vienna and the IST Park, Ribbon positions its technology for biopharmaceutical research and broader synthetic biology applications. The business is commercializing its platform and plans to set up production facilities with key technology partners. The company is preparing for expansion into the US market and has ambitious hiring plans for operational and scientific roles. Its recent financing provides capital to scale production and support commercialization activities.
Team
Richard Tsai
Founder & Managing Partner
LinkedIn